Based in Prachuabkirikhan Province, Thailand, KAMBIS is a premier Thai-owned medical cannabis enterprise operating a GACP-compliant indoor cultivation facility that bridges the gap between local agricultural excellence and global pharmaceutical standards.
Founded in 2023, our facility maintains a continuous harvest cycle, yielding over 2,000 kg of high-THC, medical-grade dry flower annually. Our optimized cultivation process ensures a steady supply of export-ready products for our global clientele.
Every stage of the cultivation process is carefully monitored using a combination of advanced techniques and human touch. Each batch undergoes daily inspections to ensure we are consistently producing at the highest standard.
KAMBIS was founded with a clear and responsible objective: to produce safe, consistent, and compliant medical cannabis, while contributing positively to the local community. The operation was designed from the outset for medical and export readiness, emphasizing controlled indoor environments, documented processes, traceability, and long-term operational sustainability.
KAMBIS does not pursue growth at the expense of quality. Every decision prioritizes patient safety, regulatory compliance, and long-term credibility.
KAMBIS operates a sophisticated, climate-controlled indoor facility engineered to meet the world’s most stringent pharmaceutical cultivation standards and international quality benchmarks. Each functional area is physically separated to ensure hygiene, contamination control, environmental stability, and full batch traceability.
Facility Overview:
– 2,850 sqm of indoor cultivation space
– 12 independent flowering rooms
– 2 large mother plant rooms for genetic stability
– 1 dedicated cloning facility
– 2 hang-drying rooms, each 1,100 sqm
– 1 large trimming and post-harvest processing facility
High-THC medical cannabis cultivated under controlled indoor conditions.
– Over 30,720 plants harvested annually
– Over 2,000 kg of medical grade dry flowers cultivated annually
– Exclusive focus on high-THC medical cannabis strains
– Indoor, year-round cultivation
– Fully documented, batch-based production cycles
In early 2025, KAMBIS became one of the first Thai medical cannabis farms to legally export to Europe. All export activities comply fully with Thai medical cannabis regulations, Thai GACP and EU GACP standards, and the import requirements of destination countries.
KAMBIS works exclusively with licensed and regulated international partners.
At KAMBIS, we believe ethical employment is the foundation of excellence.
As a Thai-owned enterprise, we are dedicated to long-term sustainability through local employment, empowering our community via structured training, comprehensive healthcare, and a safe workplace. Today, we are proud to be recognized as a premier employer of choice and a catalyst for professional innovation in the local region.
At KAMBIS, we believe that patients deserve consistent, predictable and high-purity supply of medical grade cannabis.
Our objective is not merely to cultivate cannabis, but to establish a trusted medical cultivation operation that upholds international standards and reflects positively on Thailand’s role in the global medical supply chain.
